All News

The FDA granted ribociclib a priority review to a new drug application for certain patients with breast cancer.

In an interview with CURE, James Allison, Ph.D. talks about the progress immunotherapy has made, as well as potential combinations with immunotherapy and other treatment types to provide better outcomes for patients.

Lynparza imrpoved progresion-free survival (PFS) when compared to the placebo group in a phase 3 ovarian cancer trial.

Patients with cognitive impairments from cancer treatment may be able to boost their brain power with a new online tool.

A new online tool can help patients with lymphedema through short exercise videos.

Sometimes you can find comfort and a little bit of relief in an irrational (and a bit silly) behavior.

CURE spoke with Scott Richard, M.D., about ovarian cancer recurrence and barriers women may face the second time around.

The FDA granted brigatinib a priority review for the treatment of certain patients with non-small cell lung cancer.

Treatment and imaging advancements are drastically changing the landscape of sarcoma care.

A new policy laid out by the U.S. Department of Health and Human Services is aimed at improving clinical trials.

While colorectal cancer on the left side may have a survival benefit, the stage of the cancer may pay an important role.

A new online tool will help patients with cancer engage in clearer, more meaningful conversations with their care providers.

The recent screening of the Moving Mountains for Multiple Myeloma documentary got people asking, "Where's your Kilimanjaro?"

Patients with activated B-cell-like lymphoma may not respond to standard treatment, so new options are being explored.

Breast cancer and melanoma survivor finds herself waiting for results again.

A new toolkit developed by the Society for Gynecologic Oncology is aimed at increasing awareness about genetic testing for gynecologic cancers.

CURE spoke with expert Jason Luke about updates and future prospects for immunotherapy in melanoma.

Updated trial data shows that Opdivo had a high objective response rate for a cohort of patients with classical Hodgkin Lymphoma.

Vitamin D plays an important role in helping fight breast cancer.

The party is over. Now what?

Mache Seibel discusses the benefits of taking estrogen supplements for women who harbor the BRCA genetic mutation.

Androgen deprivation therapy may be linked to dementia in men with prostate cancer, according to a recent study.

Do I want to be asked how I am doing? A six year breast cancer and three-year melanoma survivor ponders this question.

There's a heartbreaking reality of making a profession out of cancer, but I chose it anyway.

The FDA approved Keytruda to treat metastatic non-small cell lung cancer in the frontline setting.

A recent study showed that caregivers of patients with high-grade gliomas experience a great amount of time burden, even in the earlier stages of diagnosis.

Three treatment options for localized prostate cancer all showed a similar low prostate-specific mortality rate.

Research in preventing that tingling and numbness in feet and hands is progressing slowly, but what can those of us already living with it do?